Business Description
Cigna Corp
NAICS : 524114
SIC : 6324
Description
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 18 million medical members covered as of the end of September 2022.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.31 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | 2.53 | |||||
| Interest Coverage | 7.96 | |||||
| Piotroski F-Score | 7/9 | |||||
| Beneish M-Score | -6.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 37.4 | |||||
| 3-Year EBITDA Growth Rate | 18.3 | |||||
| 3-Year EPS without NRI Growth Rate | 14.3 | |||||
| 3-Year FCF Growth Rate | 10.4 | |||||
| 3-Year Book Growth Rate | 10.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.11 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.24 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 5.24 | |||||
| 9-Day RSI | 9.01 | |||||
| 14-Day RSI | 10.61 | |||||
| 6-1 Month Momentum % | 10.37 | |||||
| 12-1 Month Momentum % | 31.61 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.61 | |||||
| Dividend Payout Ratio | 0.21 | |||||
| 3-Year Dividend Growth Rate | 364.2 | |||||
| Forward Dividend Yield % | 1.64 | |||||
| 5-Year Yield-on-Cost % | 43.23 | |||||
| 3-Year Average Share Buyback Ratio | 5.4 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Net Margin % | 3.67 | |||||
| ROE % | 14.28 | |||||
| ROA % | 4.36 | |||||
| ROIC % | 6.41 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.96 | |||||
| Forward PE Ratio | 11.82 | |||||
| PE Ratio without NRI | 13.96 | |||||
| Shiller PE Ratio | 21.37 | |||||
| Price-to-Owner-Earnings | 8.06 | |||||
| PEG Ratio | 0.64 | |||||
| PS Ratio | 0.52 | |||||
| PB Ratio | 1.98 | |||||
| Price-to-Free-Cash-Flow | 9.76 | |||||
| Price-to-Operating-Cash-Flow | 8.63 | |||||
| EV-to-EBIT | 11.69 | |||||
| EV-to-Forward-EBIT | 12.33 | |||||
| EV-to-EBITDA | 8.93 | |||||
| EV-to-Forward-EBITDA | 9.96 | |||||
| EV-to-Revenue | 0.62 | |||||
| EV-to-Forward-Revenue | 0.59 | |||||
| EV-to-FCF | 11.63 | |||||
| Price-to-Projected-FCF | 0.71 | |||||
| Price-to-Median-PS-Value | 0.67 | |||||
| Earnings Yield (Greenblatt) % | 8.55 |
